In terms of somatic copy-number alterations, Atox1 is subjected to a deletion process in a high percentage of skin cutaneous melanoma (SKCM) samples (8.7%), while the deletion percentage, for either gene, could not exceed the 5% value for all the remaining 13 cancers studied (Fig. 9B). Here, ATOX1 is linked to cancer.